CreditReports.dk
HomeScreen companies

DANIPHARM A/S Financials, key figures and credit report

CVR number: 12335040 Established 1988 Industry: 21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
Company contact details
Englandsvej 350-356, 2770 Kastrup tel: 70103020
Gross profit 37 586.8 kDKK FY 2024 +38.7% vs 2023
EBIT 17 061.9 kDKK FY 2024 +142.8% vs 2023
Net debt 28 890.0 kDKK FY 2024 +3% vs 2023
Quick ratio 2.0 FY 2024 +0.2 vs 2023

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit29 394.5834 935.0835 151.5427 101.5637 586.75
Employee benefit expenses-22 491.17-23 416.42-24 795.10-17 922.11-18 442.16
Total depreciation-2 334.17-2 301.76-2 300.11-2 151.61-2 082.74
EBIT4 569.239 216.918 056.337 027.8517 061.85
Other financial income700.872 210.24932.851 472.642 605.26
Other financial expenses-1 497.63- 928.41-2 083.44-1 948.52-2 083.90
Pre-tax profit3 772.4710 498.746 905.756 551.9717 583.21
Income taxes- 828.43-2 308.03-1 514.97-1 438.32-3 865.91
Net earnings2 944.048 190.715 390.785 113.6513 717.30

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Land and waters3 104.393 017.352 932.282 846.992 761.92
Buildings13 967.6911 945.1810 074.018 007.706 686.17
Tangible assets total17 072.0814 962.5213 006.2910 854.699 448.09
Investments total
Long term receivables total
Semifinished products4 968.167 464.907 244.175 958.20
Raw materials and consumables4 053.386 627.463 052.787 277.98
Finished products/goods1 542.519 890.821 618.3541.912 142.01
Inventories total10 564.059 890.8215 710.7110 338.8615 378.18
Current trade debtors4 789.456 502.528 437.206 321.455 553.32
Current amounts owed by group member comp.39 265.2646 539.4351 990.5967 697.7382 307.89
Prepayments and accrued income485.49406.95246.08350.55298.00
Current other receivables5.964.904.166.91
Short term receivables total44 546.1653 453.7960 673.8774 373.8988 166.12
Cash and bank deposits995.290.100.061.950.23
Cash and cash equivalents995.290.100.061.950.23
Balance sheet total (assets)73 177.5778 307.2389 390.9395 569.39112 992.62

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital500.00500.00500.00500.00500.00
Shares repurchased2 000.0040 000.00
Retained earnings24 424.4727 368.5135 559.2240 950.006 063.65
Profit of the financial year2 944.048 190.715 390.785 113.6513 717.30
Shareholders equity total29 868.5136 059.2241 450.0046 563.6560 280.95
Provisions1 807.621 801.121 845.481 624.861 534.46
Non-current loans from credit institutions3 200.00
Non-current deferred tax liabilities1 470.611 658.953 956.30
Non-current liabilities total3 200.001 470.611 658.953 956.30
Current loans from credit institutions25 048.8524 206.8624 622.3724 313.3324 250.00
Advances received3 896.163 358.67
Current trade creditors7 029.029 972.3713 630.329 212.4711 700.37
Current owed to group member689.623 730.844 640.19
Short-term deferred tax liabilities715.792 314.532 314.531 470.61
Other non-interest bearing current liabilities5 507.783 953.143 368.013 098.543 271.67
Current liabilities total38 301.4440 446.8944 624.8445 721.9447 220.91
Balance sheet total (liabilities)73 177.5778 307.2389 390.9395 569.39112 992.62
Page generated